Histocell SL

About:

Histocell SL is a biopharmaceutical company that develops cell therapy products and novel medical devices for regenerative medicine.

Website: http://www.histocell.com/

Top Investors: EASME - EU Executive Agency for SMEs, Seed Capital Bizkaia, Gestion De Capital Riesgo Del Pais Vasco, Orza Investments

Description:

Histocell SL is a biopharmaceutical company that develops cell therapy products and novel medical devices for regenerative medicine. Histocell works to improve people’s quality of life by creating new Cell Therapy medicaments. Histocell facilities (567 m2) include a 65 m2 GMP-certified manufacturing facility for cell therapy medicinal products, and several laboratories for quality control and R&D activities. Histocell team meets the maximum quality standards through GMP and ISO 9001/2000 certifications.

Total Funding Amount:

$7.69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Derio, Pais Vasco, Spain

Founded Date:

2004-01-01

Contact Email:

info(AT)histocell.com

Founders:

Begoña Castro, Julio Font

Number of Employees:

11-50

Last Funding Date:

2017-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai